Rifampicin Hypersensitivity in a Pediatric Case of Brucellosis: A Case Report
Balıkesir Medical Journal·
- DOI
- 10.33716/bmedj.1862973
- PMID
- —
- PMCID
- —
- OpenAlex
- —
- Study type
- Journal article
- Publisher
- Balikesir Medical Journal
- Article type
- journal-article
- Integrity
- current
Why this research matters now
The abstract identifies drug hypersensitivity as a complication that can restrict treatment options and resemble brucellosis relapse or other complications. The report may therefore be relevant for recognizing a treatment-related event in pediatric brucellosis, but it provides evidence from one case only.
Structured evidence summary
Research question
The report describes rifampicin hypersensitivity during treatment of confirmed brucellosis in a child and documents the subsequent treatment course.
Study design
Single-patient pediatric case report with clinical follow-up after suspected rifampicin hypersensitivity and treatment modification.
Population and setting
A previously healthy 10-year-old boy with brucellosis and recent close contact with sheep. The case involved fever and left knee pain, with diagnosis supported by standard agglutination and Coombs tests.
Main findings
After two weeks of doxycycline and rifampicin, the child developed fever, vomiting, pruritus, conjunctivitis, eosinophilia, and elevated transaminases. Symptoms resolved after rifampicin withdrawal and returned after re-exposure; the patient subsequently recovered after treatment with doxycycline and gentamicin.
Public-health relevance
The abstract identifies drug hypersensitivity as a complication that can restrict treatment options and resemble brucellosis relapse or other complications. The report may therefore be relevant for recognizing a treatment-related event in pediatric brucellosis, but it provides evidence from one case only.
Important limitations
This is a single case report, so the findings do not establish frequency, comparative treatment effectiveness, or broader pediatric applicability. This summary relies only on the supplied single-article abstract and metadata; the original paper is required for decision-grade interpretation.
GIDS interpretation
The article is discoverable under brucellosis, One Health, and treatment, and provides case-level context about rifampicin hypersensitivity during pediatric brucellosis therapy. It does not provide evidence that surveillance data confirm the reported event or indicate a broader signal.
Related GIDS surveillance
Literature context does not validate, explain, or change a surveillance signal. Exact and contextual relationships are shown separately.
Evidence relationships
This article has 7 auditable classifier relationships to diseases, places, topics, and study design.